Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial

PURPOSE: Gadoxetic acid uptake on hepatobiliary phase MRI has been shown to correlate with ß-catenin mutation in patients with HCC, which is associated with resistance to certain therapies. This study aimed to evaluate the prognostic value of gadoxetic acid uptake on hepatobiliary phase MRI in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Öcal, Osman, Rössler, Daniel, Gasbarrini, Antonio, Berg, Thomas, Klümpen, Heinz-Josef, Bargellini, Irene, Peynircioglu, Bora, van Delden, Otto, Schulz, Christian, Schütte, Kerstin, Iezzi, Roberto, Pech, Maciej, Malfertheiner, Peter, Sangro, Bruno, Ricke, Jens, Seidensticker, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349099/
https://www.ncbi.nlm.nih.gov/pubmed/34541612
http://dx.doi.org/10.1007/s00432-021-03803-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349099/
https://www.ncbi.nlm.nih.gov/pubmed/34541612
http://dx.doi.org/10.1007/s00432-021-03803-3

Ejemplares similares